LOSTOCK PHARMACHEM LIMITED
Executive Summary
Lostock Pharmachem Limited is currently dormant with sustained negative net asset values indicating financial distress and potential solvency risk. While regulatory filings are up to date and management appears stable, the lack of operational activity combined with significant liabilities presents notable concerns for investors. Further investigation is needed into creditor obligations and strategic intentions to ascertain future viability.
View Full Analysis Report →- Legal registered address
- Lynstock House Lynstock Way Bolton United Kingdom BL6 4SA Copied!
Latest financial results as of 3 August 2025- Current creditors
- £62.65k
- Shareholders funds
- £-62.55k
View full financial accounts- Current creditors
- £62.65k
- Shareholders funds
- £-62.55k
- Company number
- 13111184 Copied!
Accounts
Latest annual accounts were to 31 January 2024
Next annual accounts are due by 31 October 2025
Company financial year end is on 31 January 2026
Confirmation statement
Latest confirmation statement statement dated 6 December 2024
Next statement due by 20 December 2025
Nature of business (SIC)
82990 - Other business support service activities not elsewhere classified
Latest company documents
| Date | Description |
|---|---|
| 23/07/2523 July 2025 New | Termination of appointment of Adam Collins as a director on 2025-07-15 |
| 09/01/259 January 2025 | Confirmation statement made on 2024-12-06 with no updates |
| 22/10/2422 October 2024 | Accounts for a dormant company made up to 2024-01-31 |
| 31/01/2431 January 2024 | Annual accounts for year ending 31 Jan 2024 |
| 18/01/2418 January 2024 | Confirmation statement made on 2023-12-06 with updates |
More Company Information
Recently Viewed
Follow Company
- Receive an alert email on changes to financial status
- Early indications of liquidity problems
- Warns when company reporting is overdue
- Free service, no spam emails Follow this company